Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Tigecycline market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Tigecycline market segmented into
Gram Positive Bacteria
Gram Negative Bacteria
Based on the end-use, the global Tigecycline market classified into
Skin & Soft Tissue Infections
Complicated Intra-abdominal Infections
Community-acquired Bacterial Pneumonia
Based on geography, the global Tigecycline market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Pfizer
Hisun Pharma
Hansoh Pharma
Jiagsu Aosaikang Pharmaceutical
HICIN Pharma
Abbott Laboratories
Amgen
Astrazeneca
Merck
Novartis
Roche Holdings
Johnson & Johnson
Sanofi
Lifecare Innovations
Progen Nutraceuticals
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL TIGECYCLINE INDUSTRY
2.1 Summary about Tigecycline Industry
2.2 Tigecycline Market Trends
2.2.1 Tigecycline Production & Consumption Trends
2.2.2 Tigecycline Demand Structure Trends
2.3 Tigecycline Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Gram Positive Bacteria
4.2.2 Gram Negative Bacteria
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Skin & Soft Tissue Infections
4.3.2 Complicated Intra-abdominal Infections
4.3.3 Community-acquired Bacterial Pneumonia
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Gram Positive Bacteria
5.2.2 Gram Negative Bacteria
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Skin & Soft Tissue Infections
5.3.2 Complicated Intra-abdominal Infections
5.3.3 Community-acquired Bacterial Pneumonia
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Gram Positive Bacteria
6.2.2 Gram Negative Bacteria
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Skin & Soft Tissue Infections
6.3.2 Complicated Intra-abdominal Infections
6.3.3 Community-acquired Bacterial Pneumonia
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Gram Positive Bacteria
7.2.2 Gram Negative Bacteria
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Skin & Soft Tissue Infections
7.3.2 Complicated Intra-abdominal Infections
7.3.3 Community-acquired Bacterial Pneumonia
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Gram Positive Bacteria
8.2.2 Gram Negative Bacteria
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Skin & Soft Tissue Infections
8.3.2 Complicated Intra-abdominal Infections
8.3.3 Community-acquired Bacterial Pneumonia
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Gram Positive Bacteria
9.2.2 Gram Negative Bacteria
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Skin & Soft Tissue Infections
9.3.2 Complicated Intra-abdominal Infections
9.3.3 Community-acquired Bacterial Pneumonia
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Pfizer
10.1.2 Hisun Pharma
10.1.3 Hansoh Pharma
10.1.4 Jiagsu Aosaikang Pharmaceutical
10.1.5 HICIN Pharma
10.1.6 Abbott Laboratories
10.1.7 Amgen
10.1.8 Astrazeneca
10.1.9 Merck
10.1.10 Novartis
10.1.11 Roche Holdings
10.1.12 Johnson & Johnson
10.1.13 Sanofi
10.1.14 Lifecare Innovations
10.1.15 Progen Nutraceuticals
10.2 Tigecycline Sales Date of Major Players (2017-2020e)
10.2.1 Pfizer
10.2.2 Hisun Pharma
10.2.3 Hansoh Pharma
10.2.4 Jiagsu Aosaikang Pharmaceutical
10.2.5 HICIN Pharma
10.2.6 Abbott Laboratories
10.2.7 Amgen
10.2.8 Astrazeneca
10.2.9 Merck
10.2.10 Novartis
10.2.11 Roche Holdings
10.2.12 Johnson & Johnson
10.2.13 Sanofi
10.2.14 Lifecare Innovations
10.2.15 Progen Nutraceuticals
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
Table Tigecycline Product Type Overview
Table Tigecycline Product Type Market Share List
Table Tigecycline Product Type of Major Players
Table Brief Introduction of Pfizer
Table Brief Introduction of Hisun Pharma
Table Brief Introduction of Hansoh Pharma
Table Brief Introduction of Jiagsu Aosaikang Pharmaceutical
Table Brief Introduction of HICIN Pharma
Table Brief Introduction of Abbott Laboratories
Table Brief Introduction of Amgen
Table Brief Introduction of Astrazeneca
Table Brief Introduction of Merck
Table Brief Introduction of Novartis
Table Brief Introduction of Roche Holdings
Table Brief Introduction of Johnson & Johnson
Table Brief Introduction of Sanofi
Table Brief Introduction of Lifecare Innovations
Table Brief Introduction of Progen Nutraceuticals
Table Products & Services of Pfizer
Table Products & Services of Hisun Pharma
Table Products & Services of Hansoh Pharma
Table Products & Services of Jiagsu Aosaikang Pharmaceutical
Table Products & Services of HICIN Pharma
Table Products & Services of Abbott Laboratories
Table Products & Services of Amgen
Table Products & Services of Astrazeneca
Table Products & Services of Merck
Table Products & Services of Novartis
Table Products & Services of Roche Holdings
Table Products & Services of Johnson & Johnson
Table Products & Services of Sanofi
Table Products & Services of Lifecare Innovations
Table Products & Services of Progen Nutraceuticals
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Tigecycline Market Forecast (Million USD) by Region 2021f-2026f
Table Global Tigecycline Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Tigecycline Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Tigecycline Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Tigecycline Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Tigecycline Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Tigecycline Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Tigecycline Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Tigecycline Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Tigecycline Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Tigecycline Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Gram Positive Bacteria Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Gram Negative Bacteria Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Skin & Soft Tissue Infections Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Complicated Intra-abdominal Infections Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Community-acquired Bacterial Pneumonia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Gram Positive Bacteria Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Gram Negative Bacteria Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Skin & Soft Tissue Infections Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Complicated Intra-abdominal Infections Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Community-acquired Bacterial Pneumonia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Gram Positive Bacteria Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Gram Negative Bacteria Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Skin & Soft Tissue Infections Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Complicated Intra-abdominal Infections Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Community-acquired Bacterial Pneumonia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Gram Positive Bacteria Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Gram Negative Bacteria Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Skin & Soft Tissue Infections Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Complicated Intra-abdominal Infections Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Community-acquired Bacterial Pneumonia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Gram Positive Bacteria Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Gram Negative Bacteria Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Skin & Soft Tissue Infections Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Complicated Intra-abdominal Infections Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Community-acquired Bacterial Pneumonia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Gram Positive Bacteria Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Gram Negative Bacteria Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Skin & Soft Tissue Infections Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Complicated Intra-abdominal Infections Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Community-acquired Bacterial Pneumonia Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Tigecycline Sales Revenue (Million USD) of Pfizer 2017-2020e
Figure Tigecycline Sales Revenue (Million USD) of Hisun Pharma 2017-2020e
Figure Tigecycline Sales Revenue (Million USD) of Hansoh Pharma 2017-2020e
Figure Tigecycline Sales Revenue (Million USD) of Jiagsu Aosaikang Pharmaceutical 2017-2020e
Figure Tigecycline Sales Revenue (Million USD) of HICIN Pharma 2017-2020e
Figure Tigecycline Sales Revenue (Million USD) of Abbott Laboratories 2017-2020e
Figure Tigecycline Sales Revenue (Million USD) of Amgen 2017-2020e
Figure Tigecycline Sales Revenue (Million USD) of Astrazeneca 2017-2020e
Figure Tigecycline Sales Revenue (Million USD) of Merck 2017-2020e
Figure Tigecycline Sales Revenue (Million USD) of Novartis 2017-2020e
Figure Tigecycline Sales Revenue (Million USD) of Roche Holdings 2017-2020e
Figure Tigecycline Sales Revenue (Million USD) of Johnson & Johnson 2017-2020e
Figure Tigecycline Sales Revenue (Million USD) of Sanofi 2017-2020e
Figure Tigecycline Sales Revenue (Million USD) of Lifecare Innovations 2017-2020e
Figure Tigecycline Sales Revenue (Million USD) of Progen Nutraceuticals 2017-2020e